Measles, mumps, and rubella (MMR) vaccine and Prevymis

• Generic Name: measles virus vaccine / mumps virus vaccine / rubella virus vaccine
• Dosage Forms: n.a.
• Other Brand Names: M-M-R II

Measles, mumps, and rubella are serious diseases caused by viruses spread from person to person through the air. Measles, mumps, and rubella can cause minor symptoms such as fever, headache, sore throat, cough, swollen glands, runny nose, eye irritation, skin rash, muscle aches, and joint pain.

More serious symptoms of measles or mumps include pneumonia, hearing loss, painful swelling of the testicles or ovaries, and rarely permanent brain damage or death.

Becoming infected with rubella virus (also called German Measles) during pregnancy can result in a miscarriage or serious birth defects.

The measles, mumps, and rubella (MMR) vaccine is used to help prevent these diseases by causing your body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

MMR vaccine is for use in children between the ages of 12 months and 6 years old, and in adults who have never received the vaccine or had the diseases.

Like any vaccine, the MMR vaccine may not provide protection from disease in every person.

• Generic Name: letermovir
• Dosage Forms: tablet, film coated
• Other Brand Names: Prevymis

Prevymis (letermovir) is an antiviral medicine used to help prevent cytomegalovirus (CMV) infection after a stem cell (bone marrow) transplant from a donor.

Prevymis is for use in adults who are seropositive for CMV. Seropositive means that the virus is in your blood even if you do not show any symptoms of infection.

A CMV-seropositive person is at risk for "reactivation" of the virus if the immune system becomes weak. While normally treatable, CMV infection can be serious in people undergoing a stem cell transplant.

Prevymis comes as a tablet or can be given by your doctor through an IV line (intravenously).